Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michael van Heyst
Toward Isozyme-Selective Inhibitors of Histone Deacetylase as Therapeutic Agents for the Treatment of Cancer
Pharmaceutical patent analyst
Medicine
Drug Discovery
Pharmaceutical Science
Related publications
Histone Deacetylase Inhibitors as Therapeutic Agents for Cancer Therapy: Drug Metabolism and Pharmacokinetic Properties
Histone Deacetylase Inhibitors as Cancer Therapeutics
Annals of Translational Medicine
Medicine
Discovery of Histone Deacetylase 8 Selective Inhibitors
Bioorganic and Medicinal Chemistry Letters
Organic Chemistry
Molecular Medicine
Molecular Biology
Biochemistry
Clinical Biochemistry
Pharmaceutical Science
Drug Discovery
Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
Frontiers in Oncology
Cancer Research
Oncology
Histone Deacetylase Inhibitors in Cancer Therapy
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Inhibitors of Histone-Deacetylase
Journal of Applied Biomedicine
Genetics
Molecular Biology
Pharmacology
Biochemistry
Biological Sciences
Toxicology
Medicine
Agricultural
Neuroscience
Pharmaceutics
Therapeutic Strategies to Enhance the Anticancer Efficacy of Histone Deacetylase Inhibitors
Journal of Biomedicine and Biotechnology
Preclinical Studies on Histone Deacetylase Inhibitors as Therapeutic Reagents for Endometrial and Ovarian Cancers
Future Oncology
Medicine
Cancer Research
Oncology
Thioredoxin in Cancer—Role of Histone Deacetylase Inhibitors
Seminars in Cancer Biology
Cancer Research
